Collectively, these findings indicate that silencing of Gαi3 by aav-shGαi3-s1 injection effectively suppressed Akt-mTOR activation and YAP/TAZ activity in priPC-1 xenografts, and inhibiting tumor growth. The gene discussed is AKT1; the disease is neoplasm.